FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

426766002: Darifenacin hydrobromide (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2007. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
2661566017 Darifenacin hydrobromide (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2675147016 Darifenacin hydrobromide en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
803981000172113 bromhydrate de darifénacine fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Darifenacin hydrobromide (substance) Is a Darifenacin (substance) false Inferred relationship Some
Darifenacin hydrobromide (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Muscarinic receptor antagonist (disposition) true Inferred relationship Some
Darifenacin hydrobromide (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Darifenacin (substance) true Inferred relationship Some
Darifenacin hydrobromide (substance) Is a Pyrrolidine true Inferred relationship Some
Darifenacin hydrobromide (substance) Is a Benzofuran (substance) true Inferred relationship Some
Darifenacin hydrobromide (substance) Is a Muscarinic receptor antagonist true Inferred relationship Some
Darifenacin hydrobromide (substance) Is a Antispasmodic (substance) true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Darifenacin 7.5mg m/r tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Darifenacin hydrobromide (substance) Inferred relationship Some
Darifenacin 15mg m/r tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Darifenacin hydrobromide (substance) Inferred relationship Some
Product containing precisely darifenacin (as darifenacin hydrobromide) 15 milligram/1 each prolonged-release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Darifenacin hydrobromide (substance) Inferred relationship Some 1
Darifenacin (as darifenacin hydrobromide) 7.5 mg prolonged-release oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Darifenacin hydrobromide (substance) Inferred relationship Some 1

This concept is not in any reference sets

Back to Start